Promethazine VC Oral Solution, (Promethazine and Phenylephrine Hydrochloride Oral Solution)

/Promethazine VC Oral Solution, (Promethazine and Phenylephrine Hydrochloride Oral Solution)
Promethazine VC Oral Solution, (Promethazine and Phenylephrine Hydrochloride Oral Solution)2018-09-06T09:12:40+00:00

Prescription Drug Name:

Promethazine VC Oral Solution, (Promethazine and Phenylephrine Hydrochloride Oral Solution)

ID:

d354d495-9cf3-4e2e-a7b2-3a6ef22e260a

Code:

34391-3

DESCRIPTION


id: 68762019-fcd5-4604-ba83-a05d5b82edfc
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3

Each 5 mL (one teaspoonful), for oral administration contains: Promethazine hydrochloride 6.25 mg; phenylephrine hydrochloride 5 mg. Alcohol 7%. Inactive Ingredients: Apricot peach flavor, ascorbic acid, citric acid, FD&C yellow #6, menthol, methylparaben, propylene glycol, propylparaben, purified water, saccharin sodium, sodium benzoate, sodium citrate and sucrose. Promethazine hydrochloride, a phenothiazine derivative, is chemically designated as (±)-10-[2-(Dimethylamino)propyl] phenothiazine monohydrochloride. Promethazine hydrochloride occurs as a white to faint yellow, practically odorless, crystalline powder which slowly oxidizes and turns blue on prolonged exposure to air. It is soluble in water and freely soluble in alcohol. It has a molecular weight of 320.88, a molecular formula of C17H20N2S•HCI, and the following structural formula: Phenylephrine hydrochloride is a sympathomimetic amine salt which is chemically designated as (-)-m-Hydroxy-α-[(methylamino)methyl] benzyl alcohol hydrochloride. It occurs as white or nearly white crystals, having a bitter taste. It is freely soluble in water and alcohol. Phenylephrine hydrochloride is subject to oxidation and must be protected from light and air. It has a molecular weight of 203.67, a molecular formula of C9H13NO2•HCI, and the following structural formula:

INDICATIONS AND USAGE


id: efb10411-da25-4842-a92b-318f18f95062
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9

Promethazine and phenylephrine hydrochloride oral solution is indicated for the temporary relief of upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.

CONTRAINDICATIONS


id: eabe96db-cde4-41ff-b499-ea8fa4febff4
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3

Promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. Phenylephrine is contraindicated in patients with hypertension or with peripheral vascular insufficiency (ischemia may result with risk of gangrene or thrombosis of compromised vascular beds). Phenylephrine should not be used in patients known to be hypersensitive to the drug or in those receiving a monoamine oxidase inhibitor (MAOI).

PRECAUTIONS


id: bdf2bce4-47b0-44e1-b1f3-83ecf0ffd6f8
displayName: PRECAUTIONS SECTION
FDA Article Code: 42232-9

Animal reproduction studies have not been conducted with the drug combination—promethazine and phenylephrine. It is not known whether this drug combination can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Promethazine and phenylephrine should be given to a pregnant woman only if clearly needed.

ADVERSE REACTIONS


id: 2f9f3800-50e4-4ca1-8230-2e68421efd41
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4

Promethazine: Central Nervous System – Drowsiness is the most prominent CNS effect of this drug. Sedation, somnolence, blurred vision, dizziness; confusion, disorientation, and extrapyramidal symptoms such as oculogyric crisis, torticollis, and tongue protrusion; lassitude, tinnitus, incoordination, fatigue, euphoria, nervousness, diplopia, insomnia, tremors, convulsive seizures, excitation, catatonic-like states, hysteria. Hallucinations have also been reported. Cardiovascular – Increased or decreased blood pressure, tachycardia, bradycardia, faintness. Dermatologic – Dermatitis, photosensitivity, urticaria. Hematologic – Leukopenia, thrombocytopenia, thrombocytopenic purpura, agranulocytosis. Gastrointestinal – Dry mouth, nausea, vomiting, jaundice. Respiratory – Asthma, nasal stuffiness, respiratory depression (potentially fatal) and apnea (potentially fatal). (See WARNINGS – Promethazine; Respiratory Depression.) Other – Angioneurotic edema. Neuroleptic malignant syndrome (potentially fatal) has also been reported. (See WARNINGS – Promethazine; Neuroleptic Malignant Syndrome.) Paradoxical Reactions – Hyperexcitability and abnormal movements have been reported in patients following a single administration of promethazine HCI. Consideration should be given to the discontinuation of promethazine HCl and to the use of other drugs if these reactions occur. Respiratory depression, nightmares, delirium, and agitated behavior have also been reported in some of these patients. Phenylephrine: Nervous System – Restlessness, anxiety, nervousness, and dizziness. Cardiovascular – Hypertension (see “ WARNINGS “). Other – Precordial pain, respiratory distress, tremor, and weakness.

DOSAGE AND ADMINISTRATION


id: df55f4f0-98a8-4771-9077-bc7e4c05e160
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7

Promethazine and phenylephrine hydrochloride oral solution is contraindicated for children under 2 years of age (see WARNINGS – Black Box Warning and Use In Pediatric Patients
).
The recommended doses are given in the following table: Adults And Children 12 Years And Over
1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours.
Children 6 To Under 12 Years Of Age
½ to 1 teaspoonful (2.5 to 5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours.
Children 2 To Under 6 Years Of Age
¼ to ½ teaspoonful (1.25 to 2.5 mL) every 4 to 6 hours.

HOW SUPPLIED


id: a6091c21-4a4c-4dc3-937a-df008e5e634f
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5

This preparation is a yellowish-orange oral solution with odor of apricot peach. Each 5 mL (one teaspoonful) contains promethazine hydrochloride 6.25 mg, phenylephrine hydrochloride 5 mg, and alcohol 7 percent, and is available in a one pint (473 mL) bottle NDC 0603-1587-58.

PRINCIPAL DISPLAY PANEL


id: eb5ed945-f3b6-4505-99a5-8babdb3bb4a1
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4